Renal bone disease 1990 : an unmet challenge for the nephrologistMALLUCHE, H; FAUGERE, M.-C.Kidney international. 1990, Vol 38, Num 2, pp 193-211, issn 0085-2538, 19 p.Article

Endogenous calcitonin does not protect against hyperparathyroid bone disease in renal failureMALLUCHE, H. H; FAUGERE, M.-C; RITZ, E et al.Mineral and electrolyte metabolism. 1986, Vol 12, Num 2, pp 113-118, issn 0378-0392Article

Early therapy of renal bone disease with calcitriol: a prospective double-blind studyBAKER, L. R. I; ABRAMS, S. M. L; ROE, C. J et al.Kidney international. Supplement. 1989, Num 27, pp S140-S142, issn 0098-6577Conference Paper

Comparison of different bone-biopsy techniques for qualitative and quantitative diagnosis of metabolic bone diseasesFAUGERE, M.-C; MALLUCHE, H. H.Journal of bone and joint surgery. American volume. 1983, Vol 65, Num 9, pp 1314-1319, issn 0021-9355Article

Understanding and managing hyperphosphatemia in patients with chronic renal diseaseMALLUCHE, H. H; MONIER-FAUGERE, M. C.Clinical nephrology. 1999, Vol 52, Num 5, pp 267-277, issn 0301-0430Article

Uremic bone disease : current knowledge, controversial issues, and new horizonsMALLUCHE, H. H; MONIER-FAUGERE, M.-C.Mineral and electrolyte metabolism. 1991, Vol 17, Num 4, pp 281-296, issn 0378-0392Article

Effects of 1,25(OH)₂D₃ administration on bone in patients with renal failureMALLUCHE, H. H; FAUGERE, M.-C.Kidney international. Supplement. 1990, Vol 38, Num 29, pp S48-S53, issn 0098-6577Article

Aluminium-related bone diseaseMALLUCHE, H. H; FAUGERE, M.-C.Blood purification. 1988, Vol 6, Num 1, pp 1-15, issn 0253-5068Article

Stainable aluminum and not aluminum content reflects bone histology in dialyzed patientsFAUGERE, M.-C; MALLUCHE, H. H.Kidney international. 1986, Vol 30, Num 5, pp 717-722, issn 0085-2538Article

Hyperphosphatemia : pharmacologic intervention yesterday, today and tomorrowMALLUCHE, H. H; MONIER-FAUGERE, M.-C.Clinical nephrology. 2000, Vol 54, Num 4, pp 309-317, issn 0301-0430Article

1,25(OH)₂D₃ administration in moderate renal failure: a prospective double-blind trialBAKER, L. R. I; ABRAMS, S. M. L; ROE, C. J et al.Kidney international. 1989, Vol 35, Num 2, pp 661-669, issn 0085-2538Article

Calcitriol, parathyroid hormone, and accumulation of aluminum in bone in dogs with renal failureMALLUCHE, H. H; FAUGERE, M.-C; FRIEDLER, R. M et al.The Journal of clinical investigation. 1987, Vol 79, Num 3, pp 754-761, issn 0021-9738Article

Calcitriol corrects bone loss induced by oophorectomy in ratsFAUGERE, M.-C; OKAMOTO, S; DELUCA, H. F et al.American journal of physiology. Endocrinology and metabolism. 1986, Vol 13, Num 1, pp E35-E38, issn 0193-1849Article

Treatment of aluminium toxicity in infantile uremia with deferoxamineFREUNDLICH, M; ZILLERUELO, G; FAUGERE, M.-C et al.The Journal of pediatrics. 1986, Vol 109, Num 1, pp 140-143, issn 0022-3476Article

Osteoblastic insufficiency is responsible for maintenance of osteopenia after loss of ovarian function in experimental beagle dogsMALLUCHE, H. H; FAUGERE, M.-C; RUSH, M et al.Endocrinology (Philadelphia). 1986, Vol 119, Num 6, pp 2649-2654, issn 0013-7227Article

Plasma levels of bone gal-protein reflect bone formation in patients on chronic maintenance dialysisMALLUCHE, H. H; FAUGERE, M.-C; FANTI, P et al.Kidney international. 1984, Vol 26, Num 6, pp 869-874, issn 0085-2538Article

Histomorphometric analysis of tricalcium phosphate ceramic implanted into turkeysMETSGER, D. S; ARNALA, I; FAUGERE, M.-C et al.Bone (New York, NY). 1993, Vol 14, Num 3, pp 243-248, issn 8756-3282Conference Paper

1,25-Dihydroxyvitamin D₃ corrects bone loss but suppresses bone remodeling in ovariohysterectomized beagle dogsMALLUCHE, H. H; FAUGERE, M.-C; FRIEDLER, R. M et al.Endocrinology (Philadelphia). 1988, Vol 122, Num 5, pp 1998-2006, issn 0013-7227Article

1,25-Dihydroxyvitamin D maintains bone cell activity, and parathyroid hormone modulates bone cell number in dogsMALLUCHE, H. H; MATTHEWS, C; FAUGERE, M.-C et al.Endocrinology (Philadelphia). 1986, Vol 119, Num 3, pp 1298-1304, issn 0013-7227Article

Aluminium-related bone disease in mild and advanced renal failure: evidence for high prevalence and morbidity and studies on etiology and diagnosisSMITH, A. J; FAUGERE, M.-C; ABREO, K et al.American journal of nephrology. 1986, Vol 6, Num 4, pp 275-283, issn 0250-8095Article

The use of deferoxamine in the management of aluminium accumulation in bone in patients with renal failureMALLUCHE, H. H; SMITH, A. J; ABREO, K et al.The New England journal of medicine. 1984, Vol 311, Num 3, pp 140-144, issn 0028-4793Article

Zinc nutritional status modifies renal osteodystrophy in uremic ratsKIMMEL, P. L; LANGMAN, C. B; BOGNAR, B et al.Clinical nephrology. 2001, Vol 56, Num 6, pp 445-458, issn 0301-0430Article

Structural and cellular assessment of bone quality of proximal femurDORR, L. D; FAUGERE, M.-C; MACKEL, A. M et al.Bone (New York, NY). 1993, Vol 14, Num 3, pp 231-242, issn 8756-3282Conference Paper

Five-year postoperative results of cemented femoral arthroplasty in patients with systemic bone diseaseDORR, L. D; ARNALA, I; FAUGERE, M.-C et al.Clinical orthopaedics and related research. 1990, Num 259, pp 114-121, issn 0009-921X, 8 p.Article

Role of calcitriol in the management of osteoporosisMALLUCHE, H. H; FAUGERE, M.-C.Metabolism, clinical and experimental. 1990, Vol 39, Num 4, pp 24-26, issn 0026-0495, SUPConference Paper